Does not include Pre-Conference Sessions. After content is purchased, CH is available for: $10 per session
CH expire on 3/29/2021.
Preview Available
Discuss various pharmacological agents for acute and chronic pain in the geriatric population
Continuing Education Instructions and Disclosure Information
Contact hours available until 3/29/21.
Requirements for Successful Completion:
Complete the learning activity in its entirety and complete the online CNE evaluation. You will be able to print your CNE certificate at any time after you complete the evaluation.
Conferences Committee Disclosures:
Michael Koronkowski discloses a role as a consultant for the following: OptumRx, Inc., P&T advisor; HRSA-GWEP, co-investigator; White Crane Wellness Center, Senior Programs.
There are no other disclosures to declare.
Speakers Conflict of Interest Disclosure:
There are no disclosures to declare.
Commercial Support and Sponsorship:
No commercial support or sponsorship declared.
Accreditation Statement:
This session is jointly provided by Anthony J. Jannetti, Inc. (AJJ) and the Gerontological Advanced Practice Nurses Association (GAPNA).
Anthony J. Jannetti, Inc. is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.
Anthony J. Jannetti, Inc. is a provider approved by the California Board of Registered Nursing, Provider Number CEP5387.
Learning Outcome:
After completing this learning activity, the participant will be able to discuss management of acute and chronic pain in the geriatric population.
Preview Available
Older adults experience more concurrent illnesses and are prescribed more medications. Many drugs predispose older adults to adverse events. This session focuses on prescribing and de-prescribing practices to optimize drug therapy in multimorbid older adults.
Continuing Education Instructions and Disclosure Information
Contact hours available until 3/29/21.
Requirements for Successful Completion:
Complete the learning activity in its entirety and complete the online CNE evaluation. You will be able to print your CNE certificate at any time after you complete the evaluation.
Conferences Committee Disclosures:
Michael Koronkowski discloses a role as a consultant for the following: OptumRx, Inc., P&T advisor; HRSA-GWEP, co-investigator; White Crane Wellness Center, Senior Programs.
There are no other disclosures to declare.
Speakers Conflict of Interest Disclosure:
There are no disclosures to declare.
Commercial Support and Sponsorship:
No commercial support or sponsorship declared.
Accreditation Statement:
This session is jointly provided by Anthony J. Jannetti, Inc. (AJJ) and the Gerontological Advanced Practice Nurses Association (GAPNA).
Anthony J. Jannetti, Inc. is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.
Anthony J. Jannetti, Inc. is a provider approved by the California Board of Registered Nursing, Provider Number CEP5387.
Learning Outcome:
After completing this learning activity, the participant will identify general considerations in optimizing drug therapy for elders.
Preview Available
In this session, new and future diabetes medications are reviewed.
Continuing Education Instructions and Disclosure Information
Contact hours available until 3/29/21.
Requirements for Successful Completion:
Complete the learning activity in its entirety and complete the online CNE evaluation. You will be able to print your CNE certificate at any time after you complete the evaluation.
Conferences Committee Disclosures:
Michael Koronkowski discloses a role as a consultant for the following: OptumRx, Inc., P&T advisor; HRSA-GWEP, co-investigator; White Crane Wellness Center, Senior Programs.
There are no other disclosures to declare.
Speakers Conflict of Interest Disclosure:
There are no disclosures to declare.
Commercial Support and Sponsorship:
No commercial support or sponsorship declared.
Accreditation Statement:
This session is jointly provided by Anthony J. Jannetti, Inc. (AJJ) and the Gerontological Advanced Practice Nurses Association (GAPNA).
Anthony J. Jannetti, Inc. is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.
Anthony J. Jannetti, Inc. is a provider approved by the California Board of Registered Nursing, Provider Number CEP5387.
Learning Outcome:
After completing this learning activity, the participant will be able to identify newer diabetes medications and future trends in diabetes pharmacological management.
Preview Available
Current guidelines focus on risk assessment and cardiovascular disease (CVD) risk reduction through lipid-lowering therapies. Statin medications are proven first-line medications; however, other evidence-based agents are available as add-on therapy to statins to reduce CVD events. The indications for statins, PCSK9 inhibitors, and other lipid-lowering therapies with an emphasis on older adult patients, are discussed.
Continuing Education Instructions and Disclosure Information
Contact hours available until 3/29/21.
Requirements for Successful Completion:
Complete the learning activity in its entirety and complete the online CNE evaluation. You will be able to print your CNE certificate at any time after you complete the evaluation.
Conferences Committee Disclosures:
Michael Koronkowski discloses a role as a consultant for the following: OptumRx, Inc., P&T advisor; HRSA-GWEP, co-investigator; White Crane Wellness Center, Senior Programs.
There are no other disclosures to declare.
Speakers Conflict of Interest Disclosure:
Speakers: Lynne Braun discloses that she receives a royalty from UptoDate as an author.
There are no other disclosures to declare.
Commercial Support and Sponsorship:
No commercial support or sponsorship declared.
Accreditation Statement:
This session is jointly provided by Anthony J. Jannetti, Inc. (AJJ) and the Gerontological Advanced Practice Nurses Association (GAPNA).
Anthony J. Jannetti, Inc. is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.
Anthony J. Jannetti, Inc. is a provider approved by the California Board of Registered Nursing, Provider Number CEP5387.
Learning Outcome:
After completing this learning activity, the participant will discuss risk management, guideline recommendations, and patient-centered approaches for lipid-lowering therapies for patients at intermediate or high-risk for cardiovascular disease events.
Preview Available
Common psychiatric conditions affecting older adults, appropriate use of psychotropic medications, and utilizations of pharmacogenomics to guide psychotropic medication management are discussed.
Continuing Education Instructions and Disclosure Information
Contact hours available until 3/29/21.
Requirements for Successful Completion:
Complete the learning activity in its entirety and complete the online CNE evaluation. You will be able to print your CNE certificate at any time after you complete the evaluation.
Conferences Committee Disclosures:
Michael Koronkowski discloses a role as a consultant for the following: OptumRx, Inc., P&T advisor; HRSA-GWEP, co-investigator; White Crane Wellness Center, Senior Programs.
There are no other disclosures to declare.
Speakers Conflict of Interest Disclosure:
There are no disclosures to declare.
Commercial Support and Sponsorship:
No commercial support or sponsorship declared.
Accreditation Statement:
This session is jointly provided by Anthony J. Jannetti, Inc. (AJJ) and the Gerontological Advanced Practice Nurses Association (GAPNA).
Anthony J. Jannetti, Inc. is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.
Anthony J. Jannetti, Inc. is a provider approved by the California Board of Registered Nursing, Provider Number CEP5387.
Learning Outcome:
After completing this learning activity, the participant will be able to discuss appropriate use of psychotropic medications for common psychiatric conditions of older adults, explain the definition and purpose of pharmacogenomics, and apply pharmacogenomics in the care of psychiatric conditions of older adults.
Preview Available
Treatments for heart failure, including medications and advanced options such as mechanical circulatory support and transplant, are reviewed.
Continuing Education Instructions and Disclosure Information
Contact hours available until 3/29/21.
Requirements for Successful Completion:
Complete the learning activity in its entirety and complete the online CNE evaluation. You will be able to print your CNE certificate at any time after you complete the evaluation.
Conferences Committee Disclosures:
Michael Koronkowski discloses a role as a consultant for the following: OptumRx, Inc., P&T advisor; HRSA-GWEP, co-investigator; White Crane Wellness Center, Senior Programs.
There are no other disclosures to declare.
Speakers Conflict of Interest Disclosure:
There are no disclosures to declare.
Commercial Support and Sponsorship:
No commercial support or sponsorship declared.
Accreditation Statement:
This session is jointly provided by Anthony J. Jannetti, Inc. (AJJ) and the Gerontological Advanced Practice Nurses Association (GAPNA).
Anthony J. Jannetti, Inc. is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.
Anthony J. Jannetti, Inc. is a provider approved by the California Board of Registered Nursing, Provider Number CEP5387.
Learning Outcome:
After completing this learning activity, the participant will be able to review various heart failure management options, discuss the 2017 ACC/AHA/HFSA-focused guideline update, and identify advanced heart failure patients.
Preview Available
This session focuses on the challenges of anticoagulation treatment in older adults, given the high risk for thrombotic events and anti-coagulation-associated bleeding. The clinical profiles of the various anticoagulants are reviewed, including a detailed look at the direct oral anticoagulant medications.
Continuing Education Instructions and Disclosure Information
Contact hours available until 3/29/21.
Requirements for Successful Completion:
Complete the learning activity in its entirety and complete the online CNE evaluation. You will be able to print your CNE certificate at any time after you complete the evaluation.
Conferences Committee Disclosures:
Michael Koronkowski discloses a role as a consultant for the following: OptumRx, Inc., P&T advisor; HRSA-GWEP, co-investigator; White Crane Wellness Center, Senior Programs.
There are no other disclosures to declare.
Speakers Conflict of Interest Disclosure:
There are no disclosures to declare.
Commercial Support and Sponsorship:
No commercial support or sponsorship declared.
Accreditation Statement:
This session is jointly provided by Anthony J. Jannetti, Inc. (AJJ) and the Gerontological Advanced Practice Nurses Association (GAPNA).
Anthony J. Jannetti, Inc. is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.
Anthony J. Jannetti, Inc. is a provider approved by the California Board of Registered Nursing, Provider Number CEP5387.
Learning Outcome:
After completing this learning activity, the participant will be able to compare and contrast the clinical profiles of currently available oral anticoagulants and identify the most optimal anticoagulant for their patient.
Preview Available
The prescribing of COPD medications, with a focus on patient needs and inhaler devices, are reviewed.
Continuing Education Instructions and Disclosure Information
Contact hours available until 3/29/21.
Requirements for Successful Completion:
Complete the learning activity in its entirety and complete the online CNE evaluation. You will be able to print your CNE certificate at any time after you complete the evaluation.
Conferences Committee Disclosures:
Michael Koronkowski discloses a role as a consultant for the following: OptumRx, Inc., P&T advisor; HRSA-GWEP, co-investigator; White Crane Wellness Center, Senior Programs.
There are no other disclosures to declare.
Speakers Conflict of Interest Disclosure:
There are no disclosures to declare.
Commercial Support and Sponsorship:
No commercial support or sponsorship declared.
Accreditation Statement:
This session is jointly provided by Anthony J. Jannetti, Inc. (AJJ) and the Gerontological Advanced Practice Nurses Association (GAPNA).
Anthony J. Jannetti, Inc. is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.
Anthony J. Jannetti, Inc. is a provider approved by the California Board of Registered Nursing, Provider Number CEP5387.
Learning Outcome:
After completing this learning activity, the participant will be able to confidently prescribe COPD medications to meet individual patient needs.
Preview Available
Common short- and long-term treatment side effects, as well as an overview of cytopenia and anticoagulation management, are explored.
Continuing Education Instructions and Disclosure Information
Contact hours available until 3/29/21.
Requirements for Successful Completion:
Complete the learning activity in its entirety and complete the online CNE evaluation. You will be able to print your CNE certificate at any time after you complete the evaluation.
Conferences Committee Disclosures:
Michael Koronkowski discloses a role as a consultant for the following: OptumRx, Inc., P&T advisor; HRSA-GWEP, co-investigator; White Crane Wellness Center, Senior Programs.
There are no other disclosures to declare.
Speakers Conflict of Interest Disclosure:
There are no disclosures to declare.
Commercial Support and Sponsorship:
No commercial support or sponsorship declared.
Accreditation Statement:
This session is jointly provided by Anthony J. Jannetti, Inc. (AJJ) and the Gerontological Advanced Practice Nurses Association (GAPNA).
Anthony J. Jannetti, Inc. is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.
Anthony J. Jannetti, Inc. is a provider approved by the California Board of Registered Nursing, Provider Number CEP5387.
Learning Outcome:
After completing this learning activity, the participant will be able to discuss short and long-term oncology treatment side effects as well as an overview of cytopenia and anticoagulation management.
Preview Available
An overview of common infectious diseases and antimicrobials utilized in the geriatric population is provided. An update on the risk factors and antimicrobials available for multi-drug resistant organisms are also included.
Continuing Education Instructions and Disclosure Information
Contact hours available until 3/29/21.
Requirements for Successful Completion:
Complete the learning activity in its entirety and complete the online CNE evaluation. You will be able to print your CNE certificate at any time after you complete the evaluation.
Conferences Committee Disclosures:
Michael Koronkowski discloses a role as a consultant for the following: OptumRx, Inc., P&T advisor; HRSA-GWEP, co-investigator; White Crane Wellness Center, Senior Programs.
There are no other disclosures to declare.
Speakers Conflict of Interest Disclosure:
There are no disclosures to declare.
Commercial Support and Sponsorship:
No commercial support or sponsorship declared.
Accreditation Statement:
This session is jointly provided by Anthony J. Jannetti, Inc. (AJJ) and the Gerontological Advanced Practice Nurses Association (GAPNA).
Anthony J. Jannetti, Inc. is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.
Anthony J. Jannetti, Inc. is a provider approved by the California Board of Registered Nursing, Provider Number CEP5387.
Learning Outcome:
After completing this learning activity, the participant will be able to identify the most common adverse drug reactions related to prescribing antibiotics in the geriatric population and select an appropriate antimicrobial including dose and monitoring plan.